XERS Xeris Biopharma Holdings Inc. Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
23:54
Jun 09
Jim Cramer CNBC
CNBC
Xeris is the one spec to own.
Xeris Biopharma is an injectables spec stock that Cramer endorses as the one speculative position to own to satisfy speculative appetite without leverage.
XERS Xeris Biopharma Holdings Inc. Long 1ST — —

About XERS Investor Commentary

Across the available history and selected sources, Buzzberg tracks XERS (Xeris Biopharma Holdings Inc.) across 5 sources: 1 bullish vs 0 bearish calls from 5 authors. Historical directional balance: 17% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 6 total trade ideas tracked. Past 7 days, before deduplication: 2 other directions. Latest voices: Jim Cramer.